Inhibition of protein tyrosine phosphatase 1B (PTP1B) improves insulin sensitivity and therefore might protect against the development of obesity, insulin resistance, and insulin dysregulation—the common features of metabolic syndrome or type 2 diabetes [29, 39]. This evidence concerns the gene PTPN1 and Insulin resistance.